Leptin antagonism improves Rett syndrome phenotype in symptomatic Mecp2-deficient mice.
Yasmine Belaïdouni, Diabé Diabira, Pascal Salin, Mélanie Brosset-Heckel, Victoria Valsamides, Jean-Charles Graziano, Catarina Santos, Clément Menuet, Gary A. Wayman, Jean‐Luc Gaïarsa
This study shows that reducing leptin signaling alleviates Rett syndrome symptoms in Mecp2-deficient mice by improving neurological and physiological functions.
Neurotherapeutics · Apr 1, 2026Peer-reviewedNeuroscience